ReviewNeuroscience insights2024

Multiple Sclerosis and COVID-19: An Overview on Risk, Severity, and Association With Disease Modifying Therapies.

Mary Hollist et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.